Potential use of heat shock protein 90 as a biomarker for the diagnosis of human diseases

被引:2
作者
Rivas-Macho, Ane [1 ]
Romeo, Maria V. [1 ,2 ]
Rackles, Elisabeth [3 ]
Olabarria, Garbine [1 ]
Falcon-Perez, Juan Manuel [3 ,4 ,5 ]
Berganza-Granda, Jesus [1 ]
Cortajarena, Aitziber L. [2 ,5 ]
Goni-de-Cerio, Felipe [1 ]
机构
[1] GAIKER Technol Ctr, Basque Res & Technol Alliance BRTA, Zamudio, Spain
[2] Ctr Cooperat Res Biomat CICbiomaGUNE, Basque Res & Technol Alliance BRTA, San Sebastian, Spain
[3] Ctr Cooperat Res Biosci CIC bioGUNE, Exosomes Lab, Basque Res & Technol Alliance BRTA, Bizkaia Technol Pk 801, Derio, Spain
[4] Ctr Invest Biomed Red enfermedades hepat & digest, Madrid, Spain
[5] Basque Fdn Sci, Ikerbasque, Bilbao, Spain
关键词
Heat shock protein; cancer; infectious diseases; biomarker; diagnosis; MOLECULAR-MECHANISM; SERUM BIOMARKER; LUNG-CANCER; HSP90; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION; EXOSOMES; GRP94;
D O I
10.1080/14737159.2023.2246883
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
IntroductionThe heat shock protein 90 (Hsp90) is a protein involved in many different biological processes and especially in cell survival. Some of these functions require the participation of other biological molecules, so Hsp90 is a chaperone that takes part in many protein-protein interactions working as a critical signaling hub protein. As a member of the heat shock protein family, Hsp90 expression is regulated under certain environmental and/or stressful situations, therefore Hsp90 concentration can be monitored and linked to these effects.Areas coveredThis review discusses the Hsp90 expression in samples from individuals affected by different diseases (from infectious to cancer origin), and the biological consequences of these disorders, including the potential use of Hsp90 as a biomarker for the diagnosis of human diseases.Expert opinionThe potential of Hsp90 as a biomarker disease has been demonstrated in several studies in relation to infectious diseases and especially cancer. However, further research in this field is still needed, mainly to validate in statistically significant clinical studies that the detection of Hsp90 protein allows the diagnosis of some cancers at an early stage and also that it can act as a biomarker for monitoring the efficacy of their therapies.
引用
收藏
页码:875 / 884
页数:10
相关论文
共 76 条
[1]   Biomarkers for Immunotherapy of Oral Squamous Cell Carcinoma: Current Status and Challenges [J].
Almangush, Alhadi ;
Leivo, Ilmo ;
Makitie, Antti A. .
FRONTIERS IN ONCOLOGY, 2021, 11
[2]  
[Anonymous], outcomes in colon, prostate, and breast cancer
[3]  
Bhagavan NV., 2002, Medical biochemistry, V4
[4]  
cdc, What is Sepsis? | Sepsis | CDC
[5]   Immunoelectron microscopy provides evidence that tumor necrosis factor receptor-associated protein 1 (TRAP-1) is a mitochondrial protein which also localizes at specific extramitochondrial sites [J].
Cechetto, JD ;
Gupta, RS .
EXPERIMENTAL CELL RESEARCH, 2000, 260 (01) :30-39
[6]  
Csermely P, 1999, BIOESSAYS, V21, P959, DOI 10.1002/(SICI)1521-1878(199911)21:11<959::AID-BIES8>3.3.CO
[7]  
2-T
[8]   A lethal cardiotoxic-cytotoxic protein from the Indian monocellate cobra (Naja kaouthia) venom [J].
Debnath, Anindita ;
Saha, Archita ;
Gomes, Antony ;
Biswas, Sumit ;
Chakrabarti, Pinakpani ;
Giri, Biplab ;
Biswas, Ajoy K. ;
Das Gupta, Shubho ;
Gomes, Aparna .
TOXICON, 2010, 56 (04) :569-579
[9]   Identification of HSP90 as Potential Biomarker of Biliary Atresia Using Two-Dimensional Electrophoresis and Mass Spectrometry [J].
Dong, Rui ;
Deng, Panmo ;
Huang, Yanlei ;
Shen, Chun ;
Xue, Ping ;
Zheng, Shan .
PLOS ONE, 2013, 8 (07)
[10]   STRUCTURE AND PHARMACOLOGY OF ELAPID CYTOTOXINS [J].
DUFTON, MJ ;
HIDER, RC .
PHARMACOLOGY & THERAPEUTICS, 1988, 36 (01) :1-&